More Than 1 Million Americans Are Taking Ozempic and Other GLP-1s Without an Approved Reason. Is That Actually a Problem?
New research shows that off-label use of GLP-1s has surged in recent years.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on gizmodo.com — the content belongs to Gizmodo.